The Adderall Shortage Is Now One Year Old
The U.S. is facing a mystery of missing Adderall—one for which nobody has an answer. Oct. 12 marked one year since the U.S. Food and Drug Administration’s formal announcement that pharmaceutical companies were unable to produce enough Adderall, one of the common amphetamine-based medications for attention-deficit/hyperactivity disorder (ADHD). As a result, many of the 41 million ADHD patients nationwide who rely on the drug daily to stay focused and reduce impulsive behavior have faced refill delays and empty inventories at their pharmacies. Eight drug manufacturers have reported shortages of Adderall, which also means other major ADHD medications are now in short supply after psychiatrists turned to other treatment options for patients. In a year with the highest rate of drug shortages re...